Financhill
Sell
11

CTTH Quote, Financials, Valuation and Earnings

Last price:
$0.0200
Seasonality move :
-14.22%
Day range:
$0.0225 - $0.0290
52-week range:
$0.0170 - $0.1518
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.51x
Volume:
1.2K
Avg. volume:
107K
1-year change:
-35.56%
Market cap:
$1.7M
Revenue:
--
EPS (TTM):
--

Earnings Data

Next earnings date for CTTH
--
Most recent earnings per share
-$0.00
Missed by $0.00
(Mar 31/2018)
Consensus Estimate
--
(Mar 31/2018)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CTTH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2018 Q1 -- -- -$0.00 -- --
06/30/2017 Q2 -- -- -$0.01 -- --
03/31/2017 Q1 -- -- -$0.00 -- --
09/30/2016 Q3 -- -- -$0.01 -- --
06/30/2016 Q2 -- -- -$0.01 -- --
03/31/2016 Q1 -- -- -$0.01 -- --
12/31/2015 Q4 -- -- -$0.02 -- --
09/30/2015 Q3 -- -- -$0.02 -- --
06/30/2015 Q2 -- -- -$0.02 -- --

CTT Pharmaceutical Holdings Earnings Questions

  • How Much did CTT Pharmaceutical Holdings Generate in Revenue Last Quarter?

    CTT Pharmaceutical Holdings reported -- worth of top line sales in its most recent quarter.

  • Did CTT Pharmaceutical Holdings Beat Earnings Last Quarter?

    CTT Pharmaceutical Holdings announced earnings per share of -$0.00 which represents a miss of analyst forecast a -- per share.

  • Is CTT Pharmaceutical Holdings Profitable?

    CTT Pharmaceutical Holdings reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for CTT Pharmaceutical Holdings EPS Next Year?

    CTT Pharmaceutical Holdings's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.

  • When is CTT Pharmaceutical Holdings's Earnings Date?

    Currently, CTT Pharmaceutical Holdings has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on September 16, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Is Target’s Dividend Worth Buying?
Is Target’s Dividend Worth Buying?

Retail giant Target (NYSE:TGT) has been through an extremely volatile…

Where Will AST SpaceMobile Be In 5 Years?
Where Will AST SpaceMobile Be In 5 Years?

Ever tried to send a text from the Nevada desert…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
37
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
49
RGC alert for Jun 17

Regencell Bioscience Holdings [RGC] is up 16.77% over the past day.

Buy
59
SYM alert for Jun 17

Symbotic [SYM] is down 2.77% over the past day.

Sell
43
TNXP alert for Jun 17

Tonix Pharmaceuticals Holding [TNXP] is down 5.3% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock